Upgrade to SI Premium - Free Trial

Seres Therapeutics (MCRB) PT Lowered to $17 at Oppenheimer

August 3, 2018 9:25 AM
Oppenheimer lowered its price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles